210 related articles for article (PubMed ID: 26450156)
1. Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.
Bartram I; Erben U; Ortiz-Tanchez J; Blunert K; Schlee C; Neumann M; Heesch S; Baldus CD
BMC Cancer; 2015 Oct; 15():663. PubMed ID: 26450156
[TBL] [Abstract][Full Text] [Related]
2. BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia.
Heesch S; Schlee C; Neumann M; Stroux A; Kühnl A; Schwartz S; Haferlach T; Goekbuget N; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
Leukemia; 2010 Aug; 24(8):1429-36. PubMed ID: 20535151
[TBL] [Abstract][Full Text] [Related]
3. Expression of IGFBP7 in acute leukemia is regulated by DNA methylation.
Heesch S; Bartram I; Neumann M; Reins J; Mossner M; Schlee C; Stroux A; Haferlach T; Goekbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Cancer Sci; 2011 Jan; 102(1):253-9. PubMed ID: 21040219
[TBL] [Abstract][Full Text] [Related]
4. IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase.
Laranjeira AB; de Vasconcellos JF; Sodek L; Spago MC; Fornazim MC; Tone LG; Brandalise SR; Nowill AE; Yunes JA
Leukemia; 2012 May; 26(5):1001-11. PubMed ID: 22005787
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of AIOLOS induces apoptosis and enhances etoposide chemosensitivity in Jurkat leukemia cells.
Zhuang Y; Lu Y; Li D; Sun N; Ju X
Oncol Rep; 2015 Mar; 33(3):1319-25. PubMed ID: 25524659
[TBL] [Abstract][Full Text] [Related]
6. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells.
Tomimaru Y; Eguchi H; Wada H; Noda T; Murakami M; Kobayashi S; Marubashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Br J Cancer; 2010 May; 102(10):1483-90. PubMed ID: 20407444
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59.
Cheng H; Chen L; Hu X; Qiu H; Xu X; Gao L; Tang G; Zhang W; Wang J; Yang J; Huang C
J Cell Physiol; 2019 Apr; 234(4):5186-5195. PubMed ID: 30370525
[TBL] [Abstract][Full Text] [Related]
9. [Salinomycin Enhances the Apoptosis of T-cell Acute Lymphoblastic Leukemia Cell Line Jurkat Cells Induced by Vincristine].
Liu PP; Zhu JC; Liu GX; Shui CX; Li XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):653-7. PubMed ID: 26117011
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.
Li W; Jiang Z; Li T; Wei X; Zheng Y; Wu D; Yang L; Chen S; Xu B; Zhong M; Jiang J; Hu Y; Su H; Zhang M; Huang X; Geng S; Weng J; Du X; Liu P; Li Y; Liu H; Yao Y; Li P
Mol Cancer; 2015 Feb; 14():26. PubMed ID: 25644173
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia.
Wang JY; Jia XH; Xing HY; Li YJ; Fan WW; Li N; Xie SY
Mol Med Rep; 2015 Jul; 12(1):1457-64. PubMed ID: 25760224
[TBL] [Abstract][Full Text] [Related]
12. Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells.
Gao C; Liu SG; Lu WT; Yue ZX; Zhao XX; Xing TY; Chen ZP; Zheng HY; Li ZG
Mol Med Rep; 2020 Oct; 22(4):2905-2915. PubMed ID: 32945392
[TBL] [Abstract][Full Text] [Related]
13. Anti-proliferative effect of rosiglitazone in the human T-lymphocyte leukaemia cell line Jurkat cells.
Wei R; Yu F; Yang J; Gao H; Wang H; Hong T
Cell Biol Int; 2018 May; 42(5):515-524. PubMed ID: 29274299
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
[TBL] [Abstract][Full Text] [Related]
15. IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma.
Tomimaru Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Umeshita K; Kim T; Wakasa K; Doki Y; Mori M; Nagano H
Int J Cancer; 2012 Jan; 130(2):319-27. PubMed ID: 21328580
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of the augmenter of liver regeneration results in growth inhibition and increased chemosensitivity of acute T lymphoblastic leukemia cells.
Shen Y; Liu Q; Lou S; Luo Y; Sun H; Zeng H; Deng J
Oncol Rep; 2017 Nov; 38(5):3130-3136. PubMed ID: 29048676
[TBL] [Abstract][Full Text] [Related]
17. [Effect of IGFBP7 gene down-regulation on leukemia cells].
Man XR; Hu SY; Wu SY; Cen JN; Chen ZX
Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):307-10. PubMed ID: 22781724
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphoma.
Huang Z; Fang Z; Zhen H; Zhou L; Amin HM; Shi P
Leuk Lymphoma; 2014 Aug; 55(8):1876-83. PubMed ID: 24206093
[TBL] [Abstract][Full Text] [Related]
19. Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor--related apoptosis-inducing ligand-mediated apoptosis.
Akahane K; Inukai T; Zhang X; Hirose K; Kuroda I; Goi K; Honna H; Kagami K; Nakazawa S; Endo K; Kubota T; Yagita H; Koyama-Okazaki T; Sugita K
Exp Hematol; 2010 Oct; 38(10):885-95. PubMed ID: 20670671
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]